EUVIMEDEUVIMED entdecken
Kohortenstudie

Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020–2023 versus 2016–2019 in a Nation-Wide Cohort Study

Vasiliki-Kalliopi Bournia iD, George E Fragoulis iD, Panagiota Mitrou iD, Anastasios Tsolakidis iD, Konstantinos Mathioudakis iD, Dimitrios Vassilopoulos iD, Maria Tektonidou iD, Dimitrios Paraskevis iD, Petros P Sfikakis iD

Rheumatology International · 08.10.2024 · 44 (12) · 2837-2846

DOI: 10.1007/s00296-024-05733-y ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Rheumatology International, online erschienen am 08.10.2024. Verfasst von Vasiliki-Kalliopi Bournia und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Propedeutic and Internal Medicine, Joint Academic Rheumatology Programme, National and Kapodistrian University of Athens Medical …. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Lupus Erythematosus, Systemic, COVID-19. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although several studies have explored the geoepidemiology of autoimmune rheumatic diseases (ARD), trends of their frequency overtime are under-investigated. Herein, in a nation-wide study, we examine trends in the prevalence of various ARD over-time, taking also into account the Covid-19 pandemic. In this retrospective study in the entire Greek adult population (approximately 10.000.000 people), we searched the electronic prescription database of the e-Government Centre for Social Security Services using prespecified ICD-10 codes to capture all adult patients with Psoriatic Arthritis (PsA), Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc) and Polymyalgia Rheumatica or Giant Cell Arteritis (PMR/GCA). Two sequential 4-year periods, namely 2016-2019 and 2020-2023 were compared. Prevalence of RA, PsA, AxSpA, SLE and SSc increased significantly during 2020-2023 compared to 2016-2019. This applies to both genders and to all age groups for RA, PsA and AxSpA, to female patients in SLE and SSc and to patients 18-39 years in SLE and ≥ 60 years in SSc. Overall, there was 47% increase in prevalence for AxSpA (0.100% in 2016-19 vs 0.147% in 2020-23), 36.5% for PsA (0.148% vs 0.202%), 20.6% for RA (0.467% vs 0.563%), 19% for SLE (0.137% vs 0.163%) and 13% for SSc (0.023% vs 0.026%). A 16.3% decrease was evident in GCA/PMR, limited to those ≥ 40 years old. In a nation-wide study we confirm that ARD prevalence increases over-time, whereas a contribution of Covid-19 pandemic to our results during 2020-2023, cannot be excluded. Additional human, medical and financial resources will be needed to cover the increased needs of ARD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicLupus Erythematosus, SystemicCOVID-19HumansFemaleAdultMalePrevalenceMiddle AgedRetrospective StudiesAgedYoung AdultGreeceAdolescentSARS-CoV-2Arthritis, PsoriaticArthritis, Rheumatoid

Stichwörter der Autor:innen

Inflammatory arthritisMortalityPrevalenceSLESystemic sclerosis

Autor:innen und Institutionen

  • First Department of Propedeutic and Internal Medicine, Joint Academic Rheumatology Programme, National and Kapodistrian University of Athens Medical School, Athens, Greece.
  • First Department of Propedeutic and Internal Medicine, Joint Academic Rheumatology Programme, National and Kapodistrian University of Athens Medical School, Athens, Greece. geofragoul@yahoo.gr.
  • Hellenic Republic Ministry of Health, Athens, Greece.
  • IDIKA SA - E-Government Centre for Social Security Services, Athens, Greece.
  • Clinical Immunology-Rheumatology Unit, 2nd Department of Medicine and Laboratory, Joint Academic Rheumatology Programme, National and Kapodistrian University of Athens Medical School, General Hospital of Athens "Hippokr…
  • Department of Hygiene Epidemiology and Medical Statistics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

ORCID-Profile: Vasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, Anastasios Tsolakidis, Konstantinos Mathioudakis, Dimitrios Vassilopoulos, Maria Tektonidou, Dimitrios Paraskevis, Petros P Sfikakis

Zitieren

APA

Bournia, V. K., Fragoulis, G. E., Mitrou, P., Tsolakidis, A., Mathioudakis, K., Vassilopoulos, D., Tektonidou, M., Paraskevis, D., & Sfikakis, P. P. (2024). Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020–2023 versus 2016–2019 in a Nation-Wide Cohort Study. Rheumatology International, 44(12), 2837-2846. https://doi.org/10.1007/s00296-024-05733-y

Vancouver

Bournia VK, Fragoulis GE, Mitrou P, Tsolakidis A, Mathioudakis K, Vassilopoulos D, et al. Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020–2023 versus 2016–2019 in a Nation-Wide Cohort Study. Rheumatology International. 2024;44(12):2837-2846. doi:10.1007/s00296-024-05733-y

BibTeX
@article{Bournia2024,
  author = {Bournia, Vasiliki-Kalliopi and Fragoulis, George E and Mitrou, Panagiota and Tsolakidis, Anastasios and Mathioudakis, Konstantinos and Vassilopoulos, Dimitrios and Tektonidou, Maria and Paraskevis, Dimitrios and Sfikakis, Petros P},
  title = {Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020–2023 versus 2016–2019 in a Nation-Wide Cohort Study},
  journal = {Rheumatology International},
  year = {2024},
  volume = {44},
  number = {12},
  pages = {2837--2846},
  doi = {10.1007/s00296-024-05733-y}
}
Kostenlos starten →